Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study
Jingzhou Wang, Takahiro I Nakamura, Anne G Tuskey, Brian W Behm
Intest Res. 2019;17(4):496-503.   Published online 2019 Oct 14     DOI: https://doi.org/10.5217/ir.2019.00050
Citations to this article as recorded by Crossref logo
In vitro safety signals for potential clinical development of the anti-inflammatory pregnane X receptor agonist FKK6
Zdeněk Dvořák, Barbora Vyhlídalová, Petra Pečinková, Hao Li, Pavel Anzenbacher, Alena Špičáková, Eva Anzenbacherová, Vimanda Chow, Jiabao Liu, Henry Krause, Derek Wilson, Tibor Berés, Petr Tarkowski, Dajun Chen, Sridhar Mani
Bioorganic Chemistry.2024; : 107137.     CrossRef
A Gastroenterologist's guide to drug interactions of small molecules for inflammatory bowel disease
Sivan Harnik, Bella Ungar, Ronen Loebstein, Shomron Ben‐Horin
United European Gastroenterology Journal.2024;[Epub]     CrossRef
Factors contributing to flares of ulcerative colitis in North India- a case-control study
Vishavdeep Singh Rana, Gaurav Mahajan, Amol N. Patil, Anupam K. Singh, Vaneet Jearth, Aravind Sekar, Harjeet Singh, Atul Saroch, Usha Dutta, Vishal Sharma
BMC Gastroenterology.2023;[Epub]     CrossRef
Worldwide Prevalence of Polypharmacy: A Systematic Review
Beatriz Dias Januário, Natália Silva Mafra, Humberto de Souza Silva, Isabella Monteiro Carvalho, Ana Luiza Sobreira Sena, Ana Paula Gomes Soares Pereira, Newton Santos de Faria Júnior, Helton Oliveira Campos
Current Drug Metabolism.2023; 24(8): 568.     CrossRef
Deficits in Geriatric Assessment Associate With Disease Activity and Burden in Older Patients With Inflammatory Bowel Disease
Vera E.R. Asscher, Sanne N. Waars, Andrea E. van der Meulen-de Jong, Rogier J.L. Stuyt, A. Martine C. Baven-Pronk, Sander van der Marel, Rutger J. Jacobs, Jeoffrey J.L. Haans, Lennart J. Meijer, Jacqueline D. Klijnsma-Slagboom, Marijn H. Duin, Milou E.R.
Clinical Gastroenterology and Hepatology.2022; 20(5): e1006.     CrossRef
Health Care Costs and Resource Utilization Among Patients With Crohn’s Disease With and Without Perianal Fistula
Grace Chen, Vasantha Pedarla, Kyle D Null, Susan E Cazzetta, Qasim Rana Khan, David A Schwartz
Inflammatory Bowel Diseases.2022; 28(6): 870.     CrossRef
The 5Ms of Geriatrics in Gastroenterology: The Path to Creating Age-Friendly Care for Older Adults With Inflammatory Bowel Diseases and Cirrhosis
Bharati Kochar, Nneka N. Ufere, Christine S. Ritchie, Jennifer C. Lai
Clinical and Translational Gastroenterology.2022; 13(1): e00445.     CrossRef
Polypharmacy in Patients With Inflammatory Bowel Disease
Francisco Mesonero, Cristina Fernández, Eugenia Sánchez-Rodríguez, Ana García-García Paredes, Carla Senosiain, Agustín Albillos, Antonio López-Sanromán
Journal of Clinical Gastroenterology.2022; 56(3): e189.     CrossRef
Is it time to include older adults in inflammatory bowel disease trials? A call for action
Sophie Vieujean, Bénédicte Caron, Vipul Jairath, Athanase Benetos, Silvio Danese, Edouard Louis, Laurent Peyrin-Biroulet
The Lancet Healthy Longevity.2022; 3(5): e356.     CrossRef
Psychiatric Disorders in Adult and Paediatric Patients With Inflammatory Bowel Diseases – A Systematic Review and Meta-Analysis
Laura Arp, Sabine Jansson, Vibeke Wewer, Johan Burisch
Journal of Crohn's and Colitis.2022; 16(12): 1933.     CrossRef
Impact of isotretinoin on inflammatory bowel disease flare in patients with preexisting inflammatory bowel disease diagnosis: A cross-sectional study
Christina G. Lopez, Ruby Kwak, Lindsay McCormack, Guohai Zhou, Alexandra Charrow
Journal of the American Academy of Dermatology.2022; 87(6): 1399.     CrossRef
Systematic review with meta‐analysis: dietary intake in adults with inflammatory bowel disease
Kelly Lambert, Daniel Pappas, Chiara Miglioretto, Arefeh Javadpour, Hannah Reveley, Laura Frank, Michael C. Grimm, Dorit Samocha‐Bonet, Georgina L. Hold
Alimentary Pharmacology & Therapeutics.2021; 54(6): 742.     CrossRef
Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
You Sun Kim
Journal of the Korean Medical Association.2021; 64(9): 596.     CrossRef
Frailty in inflammatory bowel diseases: an emerging concept
Bharati Kochar, Ariela R. Orkaby, Ashwin N. Ananthakrishnan, Christine S. Ritchie
Therapeutic Advances in Gastroenterology.2021; 14: 175628482110254.     CrossRef
Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
Jongwook Yu, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
Gut and Liver.2021; 15(6): 858.     CrossRef
Investigation of the impact of commonly used medications on the oral microbiome of individuals living without major chronic conditions
Vanessa DeClercq, Jacob T. Nearing, Morgan G. I. Langille, Jonathan Jacobs
PLOS ONE.2021; 16(12): e0261032.     CrossRef